The Institute of Metabolic Science-Metabolic Research Laboratories (IMS-MRL) and its embedded Medical Research Council (MRC) Metabolic Diseases Unit investigate the mechanisms through which metabolic health is maintained and how this is disturbed in disease. We seek to use that knowledge to aid better treatment and prevention of obesity, Type 2 diabetes and related endocrine and metabolic diseases.
IMS-MRL research groups encompass skills in genetics, cell biology, cell signalling, neuroendocrinology, bioenergetics, human and animal physiology, experimental medicine and clinical trials.
Latest news
22 May 2025
Congratulations to Professor Stephen O'Rahilly from the IMS-MRL and Professor Jens Juul Holst (Copenhagen University, Denmark) who are joint winners of the Distinguished Service Award presented at the 2nd Lund Spring Symposium taking place in Sweden this week. Professor Holst co-discovered the hormone glucagon-like peptide...
Professor Frank Reimann announced as a new Academy of Medical Sciences Fellow
22 May 2025
The Academy of Medical Sciences (AMS) has announced its newly elected biomedical and health scientists to its prestigious Fellowship, and we are delighted that Professor Frank Reimann from the IMS-MRL is included in the list of 54 exceptional researchers. Frank is Professor of Endocrine Signalling and his research lab, in...
10 May 2025
The European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE) have announced that the w inner of the new Joint ‘Endocrinology Across the Life Course Award’ has been awarded to Professor Sadaf Farooqi during the opening session on 10 May of the Joint Congress of ESPE and ESE 2025...
